Clinical Research Support

Clinical Trials Education Office (CTEO)

Clinical Investigator Education Series

This series is designed for DF/HCC or Harvard affiliated clinicians who are or will be assuming principal investigator responsibilities for clinical trials. Registration is encouraged and can be done by accessing the on-line registration form located at the end of each session description.

Harvard Medical School has designated each session for Category 1 CMEs as indicated. The Accreditation Council for Continuing Medical Education has accredited Harvard Medical School to provide continuing education for physicians.

Contact the CTEO at CTEO@dfci.harvard.edu if you have any questions or would like more information.

FDA's Perspective on Clinical Trials and Good Clinical Practice (GCP)-David LePay, MD FDA Senior Advisor
POSTPONED
CME-Category 1 Credit Provided

Course description to be provided at a later date.
Registration Suggested: Register

General Statistics for Clinicians-DF/HCC Biostatistics Core
June 2008
CME: Category 1 Credit Provided

DF/HCC and Cancer Care in 2015
Personalized cancer medicine is our Cancer Center's Evantual care goal. Realizing this vision will require a number of important institutional changes that will affect the way we do basic and clinical research. This session will provide a glimpse of things to come.
Presented by Barrett Rollins, MD, PhD, Chief Scientific Officer for Dana-Farber Cancer Institute
August 22, 2008 10am-11am Dana 1620 Register
This session will also be videobroadcast to MGH CCPO 326 Cambridge St. 2nd Floor Conference Room

PI-Initiated Multi-Center Trials-Jeffrey Clark, MD
September 26, 2008 10:00am-11:00am Dana 1620
**This session will also be video broadcast to MGH CCPO Conference Room**
CME Pending

This session is specifically targeted at those individuals who are actively or will be responsible for an investigator-initiated multi-center trial. This session will address the considerations in the planning, design and conduct of a multi-center trials, as well as the responsibilitiesof key personnel and best practices for trial management.
Registration suggested: Register

Tissue Repository Issues- Andrea Richardson,MD
Fall 2008
CME Pending

Advanced search
Clinical Research Support Clinical Trials Education Office (CTEO) Clinical Investigator Education Series This series is designed for DF/HCC or Harvard affiliated clinicians who are or will be assuming principal investigator responsibilities for clinical trials. Registration is encouraged and can be done by accessing the on-line registration form located at the end of each session description. Harvard Medical School has designated each session for Category 1 CMEs as indicated. The Accreditation Council for Continuing Medical Education has accredited Harvard Medical School to provide continuing education for physicians. Contact the CTEO at CTEO@dfci.harvard.edu if you have any questions or would like more information. FDA's Perspective on Clinical Trials and Good Clinical Practice (GCP)-David LePay, MD FDA Senior Advisor POSTPONED CME-Category 1 Credit Provided Course description to be provided at a later date. Registration Suggested: Register General Statistics for Clinicians-DF/HCC Biostatistics Core June 2008 CME: Category 1 Credit Provided DF/HCC and Cancer Care in 2015 Personalized cancer medicine is our Cancer Center's Evantual care goal. Realizing this vision will require a number of important institutional changes that will affect the way we do basic and clinical research. This session will provide a glimpse of things to come. Presented by Barrett Rollins, MD, PhD, Chief Scientific Officer for Dana-Farber Cancer Institute August 22, 2008 10am-11am Dana 1620 Register This session will also be videobroadcast to MGH CCPO 326 Cambridge St. 2nd Floor Conference Room PI-Initiated Multi-Center Trials-Jeffrey Clark, MD September 26, 2008 10:00am-11:00am Dana 1620 This session will also be video broadcast to MGH CCPO Conference Room CME Pending This session is specifically targeted at those individuals who are actively or will be responsible for an investigator-initiated multi-center trial. This session will address the considerations in the planning, design and conduct of a multi-center trials, as well as the responsibilitiesof key personnel and best practices for trial management. Registration suggested: Register Tissue Repository Issues- Andrea Richardson,MD Fall 2008 CME Pending	Office for Human Research Studies (OHRS) Quality Assurance Office for Clinical Trials (QACT) Clinical Research Unit (CRU) Clinical Trials Education Office (CTEO) Education Services Contacts Protocol Review and Monitoring System (PRMS)
Site Map Site Feedback Web Privacy Policy